• Explore /
  • Poster
  • / A Prospective Multicenter Phase II Study of Sorafenib Combined with Cisplatin plus Gemcitabine for the Treatment of Patients with Advanced Renal Collecting Duct Carcinoma (NCT01762150).

A Prospective Multicenter Phase II Study of Sorafenib Combined with Cisplatin plus Gemcitabine for the Treatment of Patients with Advanced Renal Collecting Duct Carcinoma (NCT01762150).

Abstract Poster

Authors

null

Xinan Sheng

Peking University Cancer Hospital & Institute, Beijing, China

Xinan Sheng , Chuanliang Cui , Zhihong Chi , Lu Si , Si Ming Li , Li Li Mao , BIN LIAN , Bixia Tang , Xieqiao Yan , Xuan Wang , Yan Kong , Jianlin Yuan , Fangjian Zhou , Xiaodong Xie , Qiang Wei , Jun Guo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT01762150

Citation

J Clin Oncol 34, 2016 (suppl; abstr 4559)

DOI

10.1200/JCO.2016.34.15_suppl.4559

Abstract #

4559

Poster Bd #

181

Abstract Disclosures

Similar Posters

First Author: John Ebben

First Author: Richard D. Kim

First Author: Zhen-gang Yuan

First Author: Vaibhav Sahai